Page 2 - Nasdaq Kzia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq kzia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Kzia Today - Breaking & Trending Today

Kazia Therapeutics Limited (NASDAQ:KZIA) Short Interest Update

Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 15th, there was short interest totalling 56,900 shares, a decrease of 33.5% from the July 31st total of 85,600 shares. Based on an average daily volume of 185,800 shares, […] ....

Morgan Stanley , Exchange Commission , Kazia Therapeutics , Kazia Therapeutics Limited , Get Free Report , Free Report , Therapeutics Trading Down , Therapeutics Limited , Kazia Therapeutics Daily , Nasdaq Kzia ,

Kazia Therapeutics (NASDAQ:KZIA) Shares Down 4.6%

Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report)’s stock price fell 4.6% during mid-day trading on Tuesday . The stock traded as low as $0.85 and last traded at $0.90. 16,985 shares traded hands during trading, a decline of 85% from the average session volume of 110,825 shares. The stock had previously closed at $0.95. […] ....

Kazia Therapeutics Limited , Morgan Stanley , Kazia Therapeutics , Securities Exchange Commission , Get Free Report , Free Report , Therapeutics Limited , Kazia Therapeutics Daily , Nasdaq Kzia ,

Kazia Therapeutics (NASDAQ:KZIA) Stock Price Down 4.6%

Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report) traded down 4.6% during trading on Tuesday . The company traded as low as $0.85 and last traded at $0.90. 16,985 shares were traded during trading, a decline of 85% from the average session volume of 110,825 shares. The stock had previously closed at $0.95. Kazia Therapeutics […] ....

Morgan Stanley , Kazia Therapeutics Limited , Securities Exchange Commission , Kazia Therapeutics , Get Free Report , Free Report , Therapeutics Limited , Kazia Therapeutics Daily , Nasdaq Kzia ,

Kazia Therapeutics Limited (NASDAQ:KZIA) Short Interest Up 20.3% in May

Kazia Therapeutics Limited (NASDAQ:KZIA – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 161,500 shares, an increase of 20.3% from the May 15th total of 134,300 shares. Based on an average daily trading volume, of 33,800 shares, the short-interest ratio […] ....

Kazia Therapeutics Limited , Kazia Therapeutics , Morgan Stanley , Exchange Commission , Get Rating , Therapeutics Stock Down , Therapeutics Limited , Kazia Therapeutics Daily , Nasdaq Kzia ,

Kazia Therapeutics Limited (NASDAQ:KZIA) Sees Significant Drop in Short Interest

Kazia Therapeutics Limited (NASDAQ:KZIA – Get Rating) saw a large drop in short interest in May. As of May 15th, there was short interest totalling 134,300 shares, a drop of 24.4% from the April 30th total of 177,700 shares. Based on an average trading volume of 44,200 shares, the short-interest ratio is presently 3.0 days. […] ....

New South Wales , Graham Edmund Kelly , Kazia Therapeutics Company Profile , Kazia Therapeutics Ltd , Kazia Therapeutics Limited , Mission Capital , Get Rating , Kazia Therapeutics , Kazia Therapeutics Daily , Nasdaq Kzia ,